The European Union (EU) has implemented strict regulations to ensure biocidal products’ safe and effective use. Biocides are crucial in controlling harmful organisms such as bacteria, viruses, and pests and are widely used in various sectors, including healthcare, agriculture, and household products. Compliance with EU Biocidal Product Regulation (BPR) ensures market access and consumer protection. To navigate the complexities of BPR compliance within the EU, consider partnering with a Regulatory expert.
Malaysia has established several chemical safety regulations to protect human health and the environment from potential hazards associated with the use, handling, storage, and disposal of hazardous chemicals. This blog provides an overview of the key chemical safety regulations that are currently in place in Malaysia.
It is crucial for Regulatory bodies to monitor the vast range of consumer products available in their market. With new products entering the market regularly, this task becomes increasingly complex for Regulatory Authorities. However, it is important to detect potentially harmful products to ensure product compliance and consumer safety. The Rapid Exchange of Information System (RAPEX) is European Union’s rapid alert system to identify unsafe consumer products to ensure consumer well-being.
The year 2020 has been unpredictable for all the industries across the globe, including life sciences industry. With the outbreak of COVID-19, the life sciences industry and global Health Authorities faced various challenging scenarios, which in turn affected their long-term Regulatory plans. The global Health Authorities, along with various healthcare providers, were pushed to transform their operational models overnight to deal with the on-going crisis.
The year 2020 was a roller coaster for everyone across the world. With the outbreak of the COVID-19, global Health Authorities (HAs) have been working relentlessly to ensure that healthcare professionals and the general public have the best resources to fight this pandemic. A lot of temporary changes have been made to the regulations of various medical, medicinal and cosmetic products, such as vaccines, PPE kits, surgical masks, hand gloves, hand sanitizers, etc., to expedite their approvals and market entry, and to meet their market demand.
On July 1, 2020, the National Industrial Chemicals Notification and Assessment Scheme (NICNAS) was officially replaced by the Australian Industrial Chemicals Introduction Scheme (AICIS). Falling under the Industrial Chemicals Act 2019, the AICIS is a Regulatory scheme, which focuses on supporting cosmetic product manufacturers with easy import of new low-risk chemicals to the Australian market. The AICIS is also responsible for regulating the industrial chemicals used in the manufacturing of a cosmetic product.
Freyr Launches Exclusive Web Platforms for its BWH Business Line - Cosmetics, Food and Food Supplements, and Chemicals
As we look at these challenging times for manufacturers across the life sciences industry, of course, not in terms of manufacturing products, but to market them across the globe compliantly, we understand there is a dire need for effective Regulatory solutions and services to ensure products compliant market entry. As always, we believe that they need a dedicated approach and a clear-cut service line.
Antiseptic Washes Used in Healthcare Settings. What Should You Know About FDA’s Ban on 24 Active Ingredients?
About a year after issuing the final rule for antibacterial soaps, where it has banned 19 ingredients, the US Food and Drug Administration (FDA) has come out with an announcement on similar lines. Now, the Agency has barred the usage of 24 active ingredients including Triclosan which they no longer consider generally recognized as safe and effective (GRASE) and hence inappropriate to use in OTC antiseptic washes, hand washes, rubs and surgical hand scrubs used in healthcare settings.
The Life Sciences market is growing and is expected to reach US$ 4,200 Million by the end of 2024. At the same time, the world is turning more protective about increasing health concerns. Alongside addressing the health needs and aligning with the market scenario, the pharma, biotech, cosmetic, medical devices and healthcare organizations shouldn’t only innovate new compliant products, but also ensure that they are accessible across the globe with stringent safety and efficacy measures.
The Cosmetics and Personal Care industry is driven by the constantly evolving Regulatory landscape and focuses mainly on the safety and efficacy of cosmetic products that are released into the market. The industry is segmented into several categories like, General Cosmetics, Functional Cosmetics, Quasi drugs, Grade -I and Grade-II Cosmetics, medicated cosmetics, Controlled cosmetics (CC), Specially controlled cosmetics (SCC), OTC, Low-Risk and high-risk products, and so on.